The distribution of West Nile virus has expanded in the past 6 years to include the 48 contiguous United States and seven Canadian provinces, as well as Mexico, the Caribbean islands, and Colombia. The suggestion of the emergence of a dominant genetic variant has led to an intensive analysis of isolates made across North America. We have sequenced the pre-membrane and envelope genes of 74 isolates and the complete genomes of 25 isolates in order to determine if a dominant genotype has arisen and to better understand how the virus has evolved as its distribution has expanded. Phylogenetic analyses revealed the continued presence of genetic variants that group in a temporally and geographically dependent manner and provide evidence that a dominant variant has emerged across much of North America. The implications of these findings are discussed as they relate to transmission and spread of the virus in the Western Hemisphere.
After West Nile virus (WNV) was first detected in Florida in July 2001, intensive surveillance efforts over the following five months uncovered virus activity in 65 of the state's 67 counties with 1,106 wild birds, 492 horses, 194 sentinel chickens, and 12 people found infected with the virus. Thirteen of 28 mosquito isolations came from Culex mosquitoes. As seen in the northeastern United States, wild bird mortality was the most sensitive surveillance method. However, unlike the predominantly urban 1999 and 2000 epizootics, the Florida transmission foci were rural with most activity detected in the northern part of the state. All human cases were preceded by the detection of WNV in animals; however, only eight of the twelve cases were preceded by reports of WNV activity in the county of residence. West Nile virus−positive animals detected by multiple surveillance systems preceded seven of these cases by two weeks or more.
We describe the first documented field transmission of West Nile (WN) virus by a North American mosquito. WN was first detected in northern Florida in 2001. An intensive mosquito trapping and surveillance program was conducted in this region for four nights to assess mosquito transmission of WN. Four mosquito traps, each with a single sentinel chicken, were placed at five different locations on each of four nights. A total of 11,948 mosquitoes was collected, and 14 mosquito pools were found to contain WN, giving a minimum infection rate between 1.08 and 7.54 per 1,000. Only one of the 80 sentinel chickens seroconverted to WN, demonstrating a single mosquito transmission event during the study and a mosquito transmission rate of between 0.8 and 1 per 1,000. Culex nigripalpus Theobald was responsible for WN transmission to the sentinel chicken, although both Cx. nigripalpus and Culex quinquefasciatus Say were found infected with WN. Mosquito transmission rates are reported in this study for the first time for a WN outbreak. This information is essential to determine risk of human and animal infection.
Wild caught rock pigeons (Columba livia) with antibodies to West Nile virus were monitored for 15 months to determine antibody persistence and compare results of three serologic techniques. Antibodies persisted for the entire study as detected by epitope-blocking enzyme-linked immunosorbent assay and plaque reduction neutralization test. Maternal antibodies in squabs derived from seropositive birds persisted for an average of 27 days.West Nile virus (WNV) (Flaviviridae family, Flavivirus genus) is maintained in a bird-mosquito transmission cycle, and wild bird surveillance has proven effective in tracking the spread of this virus in North America. Since extensive avian mortality has been associated with WNV infection in North America, much of this surveillance has concentrated on deadbird testing (16). As demonstrated with other arboviruses, such as St. Louis encephalitis virus (SLEV), eastern equine encephalitis virus, and western equine encephalitis virus, serologic testing of birds represents another tool for further investigating WNV epidemiology (7,8,14).The duration of the antibody response, test performance, and persistence of maternal antibodies can complicate interpretation of serologic results. Information on the persistence of antibodies to WNV in avian species is currently limited. Experimentally, persistence of neutralizing antibodies to the North American strain of WNV in rock pigeons (Columba livia) was demonstrated over a 9-week period postinoculation and in chickens over a 28-day period postinoculation (9, 11). Pigeons inoculated with an African strain of WNV maintained antibodies for 16 months (12). Recaptured naturally infected wild birds in South Africa with initial WNV antibody titers of Ͼ40 lost demonstrable antibody by hemagglutination inhibition (HAI) in as few as 3 weeks (13).The objectives of this study were the following: (i) to determine the long-term persistence of antibodies to WNV in naturally infected rock pigeons, (ii) to compare the long-term utility of commonly used WNV serologic techniques (plaque reduction neutralization test [PRNT], HAI, and epitope-blocking enzyme-linked immunosorbent assay [ELISA]), and (iii) to determine the persistence of maternal antibodies to WNV in squabs derived from these naturally infected birds.Thirty rock pigeons, 20 seropositive for WNV and 10 negative controls, were captured in April 2003 in Atlanta, Georgia. All birds were banded and housed in a mosquito-free facility for 60 weeks. Venipuncture was performed on each bird upon entry and at 3-week intervals by wing vein. Serum samples were stored at Ϫ70°C.Using WNV (Georgia isolate DES-107-01) and SLEV (strain TBH-28), PRNTs were performed following standard protocols (1, 10). Titers were expressed as the reciprocal of serum dilutions reducing the number of plaques Ͼ90% (PRNT 90 ). Samples with PRNT 90 titers to WNV which were fourfold greater than titers to SLEV were considered seropositive for WNV. HAI assays were performed at the Florida Department of Health using a published protocol (5). Th...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.